Verrica Pharma Details Executive Compensation and Equity Awards
Ticker: VRCA · Form: DEF 14A · Filed: Apr 22, 2025 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
Related Tickers: VRCA
TL;DR
Verrica Pharma's DEF 14A shows exec comp details, including equity awards for Rieger & White.
AI Summary
Verrica Pharmaceuticals Inc. filed a DEF 14A on April 22, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including equity awards granted to individuals like Jayson Rieger and Ted White. It also outlines changes in the fair value of outstanding equity awards and vesting dates for awards granted in prior years.
Why It Matters
This filing provides transparency into how Verrica Pharmaceuticals compensates its top executives, which can influence investor decisions and perceptions of company management.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and does not contain new material financial information or strategic changes.
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Filer
- Jayson Rieger (person) — Executive Compensation Recipient
- Ted White (person) — Executive Compensation Recipient
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When was Verrica Pharmaceuticals Inc. incorporated?
Verrica Pharmaceuticals Inc. was incorporated in Delaware (DE).
What is Verrica Pharmaceuticals Inc.'s Standard Industrial Classification (SIC) code?
Verrica Pharmaceuticals Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Who are the key individuals mentioned in relation to equity awards for the fiscal year 2024?
Jayson Rieger and Ted White are mentioned in relation to equity awards for the fiscal year 2024.
What is the business address of Verrica Pharmaceuticals Inc.?
The business address of Verrica Pharmaceuticals Inc. is 10 North High Street, Suite 200, West Chester, PA 19380.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 22, 2025 by Jayson Rieger regarding Verrica Pharmaceuticals Inc. (VRCA).